Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. - Wikidata - awgldk - TriplyDB

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.

http://www.wikidata.org/entity/Q34129408

about

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report.KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome.Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case.Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.The treatment of desmoid tumors: a stepwise clinical approach.Desmoid tumour in familial adenomatous polyposis patients: responses to treatments.

P2860

Q27853040-E7B860CB-92D7-436C-980F-C4647D37C9A2 Q34168680-54B3DA22-AE3C-4724-A856-13012C814205 Q34646737-EF067F4D-8D2C-4703-B778-C21A9ADFB38A Q34782409-8048FC4A-1877-4A5D-8FDE-9964B38387B9 Q35016339-DC24A757-885B-47D8-B325-C8315D8F74BA Q35820278-DD55C7D7-6F47-41BE-AA1B-4789EC79B448 Q36074241-EC088799-4056-4340-B94E-DD245D2A119D Q36264188-806B3190-4A62-4056-9586-DC9A03A9BD39 Q36335997-96C0BC43-4ED4-4FCF-98A1-2BDFE6D793F0 Q42530532-D85A5D0F-94B0-42C3-97DA-9D739859438A Q50122182-0356B82D-9445-4CBA-AA3A-52B349B4C897 Q54279935-E07AD629-092A-4789-8723-D8E22425B324

P2860

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.

http://www.wikidata.org/entity/Q34129408

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Identification of biological f ...... te in aggressive fibromatosis.

@ast

Identification of biological f ...... te in aggressive fibromatosis.

@en

Identification of biological f ...... te in aggressive fibromatosis.

@nl

type

label

Identification of biological f ...... te in aggressive fibromatosis.

@ast

Identification of biological f ...... te in aggressive fibromatosis.

@en

Identification of biological f ...... te in aggressive fibromatosis.

@nl

prefLabel

Identification of biological f ...... te in aggressive fibromatosis.

@ast

Identification of biological f ...... te in aggressive fibromatosis.

@en

Identification of biological f ...... te in aggressive fibromatosis.

@nl

P1433

Q34129408-B634A6C1-65B6-4D3C-A8A4-D11A1CA26B7C

P1476

Q34129408-2A67CEFF-9D57-4AC0-BD79-8507130FDA05

P2093

Q34129408-037BD479-5B42-4836-9E65-E55717E1AE4D

Q34129408-064B3136-0C0F-45E0-863A-B5C9FFEA00AC

Q34129408-1ADF8DB7-A1F0-4B5A-94BE-6CE69A4D3185

Q34129408-298FF1FC-1AEE-496A-B6F9-E762C131F245

Q34129408-6AFCD3A6-2431-4247-85A3-27E4291A84FA

Q34129408-86FDBB5A-CDA4-4809-ABEE-FCE0F3ED851D

Q34129408-8B18E6CB-3BD4-4652-90BA-6CEAB3523BCC

Q34129408-D4F0B1C5-F5B1-4315-AD24-7B0772B6325B

Q34129408-E78EDF6A-3431-4434-8FF6-B6C3AF901722

Q34129408-ED0859BA-4EF3-4EBA-8800-37871D4AD061

P2860

Q34129408-0033BF3B-951F-4D69-971E-4AB322D9FF6A

Q34129408-13DABE5B-C8D4-426B-B574-FB37F6FB5FD4

Q34129408-30F64B78-E6C8-4EBA-B7BC-E2EAE32BAACD

Q34129408-5A7B860A-52A7-4B6F-97CC-F7E90773D0FB

Q34129408-7A5322BE-47D0-47B6-86AB-A3158064B91A

Q34129408-C884597B-E38C-450D-95D9-E4B102B8FB20

Q34129408-CD49E954-1513-4CD2-956E-DCBC7DE820A2

Q34129408-EEACA632-FDF6-4520-B892-3D2E27987CF1

P2888

Q34129408-CA596D61-283E-499D-8EC7-50F9C364D9BA

P304

Q34129408-016E3DAA-D868-4367-9A6A-B59BD5F0C7DE

P31

Q34129408-745F388A-9EB2-4D99-856E-A962432D773A

P356

Q34129408-454B4BBB-4B12-42A2-A112-23C88CA291D5

P407

Q34129408-7DB41680-D03D-4B0A-827F-F473036639BE

P433

Q34129408-90B93A63-FD16-48B5-BD18-CA001C0ED8DA

P478

Q34129408-F9F7521A-E267-4100-ABCC-5539C47E908F

P50

Q34129408-7FFFF3FF-9F64-4ACC-AD5A-A69F03A2274B

Q34129408-C1F8ED82-6F01-457F-92F3-96F823B52204

Q34129408-D2DE7BDC-08A2-4AD0-A639-47C3C11A3C25

P577

Q34129408-2070C2E4-42E0-4DA2-A402-6B0D98B95B77

P5875

Q34129408-F8C2EFA1-1D48-42E5-A6BD-D16544B29725

P6179

Q34129408-9D1318EF-1440-4765-AFF1-0ACCA86780E2

P698

Q34129408-0E046CC1-E517-4CFF-AF57-E5520D6BFF1F

P932

Q34129408-450A0EB2-DCFB-42B0-8E45-F0B9E2666E4A

P356

P1433

British Journal of Cancer

P1476

Identification of biological f ...... te in aggressive fibromatosis.

@en

P2093

A Dufresne

http://www.w3.org/2001/XMLSchema#string

A Goncalves

http://www.w3.org/2001/XMLSchema#string

B Bui

http://www.w3.org/2001/XMLSchema#string

C Chevreau

http://www.w3.org/2001/XMLSchema#string

D Cupissol

http://www.w3.org/2001/XMLSchema#string

D Perol

http://www.w3.org/2001/XMLSchema#string

F Bertucci

http://www.w3.org/2001/XMLSchema#string

M Jimenez

http://www.w3.org/2001/XMLSchema#string

M Tubiana-Hulin

http://www.w3.org/2001/XMLSchema#string

N Penel

http://www.w3.org/2001/XMLSchema#string

P2860

A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis.

Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles.

The pharmacological treatment of aggressive fibromatosis: a systematic review.

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors.

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.

Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.

P2888

P304

482-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605783

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Ray-Coquard

P577

2010-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45389531

http://www.w3.org/2001/XMLSchema#string

P6179

1014725469

http://www.w3.org/2001/XMLSchema#string

P698

20664593

http://www.w3.org/2001/XMLSchema#string

P932

2939782

http://www.w3.org/2001/XMLSchema#string